Ameriprise
NAVB

Ameriprise’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Ameriprise’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-680
Closed -$3K – 3825
2018
Q2 		$3K Hold
680
– – ﹤0.01% 3633
2018
Q1 		$5K Hold
680
– – ﹤0.01% 3617
2017
Q4 		$5K Buy
680
+25
+4% +$212 ﹤0.01% 3628
2017
Q3 		$5K Hold
655
– – ﹤0.01% 3665
2017
Q2 		$7K Hold
655
– – ﹤0.01% 3717
2017
Q1 		$8K Hold
655
– – ﹤0.01% 3600
2016
Q4 		$8K Hold
655
– – ﹤0.01% 3848
2016
Q3 		$12K Hold
655
– – ﹤0.01% 3749
2016
Q2 		$7K Sell
655
-111
-14% -$2.18K ﹤0.01% 3743
2016
Q1 		$14K Hold
766
– – ﹤0.01% 3721
2015
Q4 		$20K Hold
766
– – ﹤0.01% 3818
2015
Q3 		$35K Hold
766
– – ﹤0.01% 3791
2015
Q2 		$25K Sell
766
-44
-5% -$1.28K ﹤0.01% 3984
2015
Q1 		$26K Buy
+810
New +$27.4K ﹤0.01% 3753
2014
Q4 		– Sell
-418
Closed -$11K – 4754
2014
Q3 		$11K Buy
418
+56
+15% +$1.48K ﹤0.01% 4801
2014
Q2 		$11K Buy
362
+7
+2% +$226 ﹤0.01% 4630
2014
Q1 		$13K Hold
355
– – ﹤0.01% 4424
2013
Q4 		$15K Sell
355
-973
-73% -$38.1K ﹤0.01% 4201
2013
Q3 		$71K Sell
1,328
-160
-11% -$9.33K ﹤0.01% 3629
2013
Q2 		$80K Buy
+1,488
New +$74.3K ﹤0.01% 3474

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWM
Cornerstone Wealth Management St. Peters, Missouri $2B AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise's NAVB Position: Q3 2018 in Review

Ameriprise sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q3 2018, closing a stake of 680 shares — an estimated $3K sold.

Ameriprise first reported a position in NAVB in Q2 2013 and held it in 20 quarters. The position peaked at $80K in Q2 2013. 53 funds tracked by Wall St. Rank hold NAVB as of Q3 2018.

  • Ameriprise reported no remaining Navidea Biopharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Ameriprise sold 680 Navidea Biopharmaceuticals Inc. shares in Q3 2018, an estimated $3K.
  • Ameriprise first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 20 quarters.
  • Ameriprise's Navidea Biopharmaceuticals Inc. position peaked at $80K in Q2 2013.
  • 53 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q3 2018.

Based on Ameriprise's 13F filing for Q3 2018, filed 14 Nov 2018.